Abstract: Lipid peroxidation (LPX) can play an important role in development of functional and pathological changes of maternal tissues in the course of pregnancy and delivery. LPX products were measured as thiobarbituric acid reacting substances (TBARS), using malondialdehyde as the standard solution. Actual TBARS determined in maternal post-delivery plasma (2.71 ± 0.602 nmol/mL) were not statistically different from those determined in pre-delivery plasma (3.45 ± 0.530 nmol/mL). TBARS production was measured in vitro in the both incubated plasma (30 min, 37
Introduction
Oxidative stress, which is characterized as imbalance between free radicals generation and antioxidant activity, participates in the pathogenesis of various complications in the course of pregnancy and perinatal period (Cester et al. 1992; Poranen et al. 1996; Žitňanová et al. 2007) . A strong oxidative stress was characterized by an increase of free radicals production in maternal tissues during the pathological pregnancy (Mutlu-Türkoglu et al. 1998) . The perinatal period represents a significant oxidative stress for foetus (Žitňanová et al. 2004; Brucknerová et al. 2005) . The potential damage of cells that can be caused by free radicals is physiologically minimized by antioxidant systems that serve to control peroxidation (Davidge et al. 1992) .
Lipid peroxidation (LPX) is an oxidative process that occurs continuously at low levels in all human cells and tissues (Little & Gladen 1999) . It has been suggested that uncontrolled LPX may play an important role in the development of functional and pathological changes of foetal (Bankova et al. 1989 ) and maternal tissues in the course of pregnancy (Kharb et al. 1998; Rogers et al. 1999) . Measurement of LPX products provides an index of cell membrane LPX and an estimate of the cumulative oxidation activity of oxygen free radicals generation in various biological systems (Halliwell & Gutteridge 1999) . The human placenta (Gülmezoglu et al. 1996) , endothelial cells of umbilical cord or maternal vessels (Yaacobi et al. 1999 ) could be potential sources of LPX products secreted into maternal and foetal circulation.
LPX products, such as thiobarbituric acid (TBA) reacting substances (TBARS) and malondialdehyde (MDA), were used for investigation of LPX intensity in maternal or umbilical cord plasma of newborns (Wang Yaacobi et al. 1999; Kaya et al. 2000; Paşaoglu et al. 2004) . Wang et al. (1996) reported association between MDA levels and acid-base balance (ABB) parameters in umbilical cord blood, which reflected foetal tissue injury at birth. Moreover, according to Rogers et al. (1998) , TBARS might be a more sensitive indicator of foetal hypoxia than ABB parameters in umbilical cord blood.
In some clinical studies, LPX was investigated in the process of labour by determination of TBARS in maternal pre-delivery and post-delivery plasma (Nakai et al. 2000; Kobe et al. 2002; Orhan et al. 2003) . Rogers et al. (1999) presented higher MDA levels in plasma of infants born by uncomplicated spontaneous delivery than in those born by caesarean section. Additionally, they observed the positive correlation between the MDA in maternal plasma and the MDA in arterial umbilical cord plasma, which originated from foetus. According to them, uncomplicated spontaneous delivery can cause an increase of LPX products levels in umbilical cord plasma of newborns (Rogers et al. 1999) .
One of the aims of our study was therefore to determine not only the actual TBARS in maternal pre-delivery and post-delivery plasma, but to measure TBARS formation in vitro during experimentally activated LPX (incubation of plasma or/and addition of L-ascorbate and Fe 2+ ). It could help to evaluate better the activation of TBARS production in vitro. This entire procedure can reveal the influence of the labour on conditions and effectors, which could activate TBARS production in maternal plasma. Zima et al. (1995) reported that MDA, as a minor product of LPX reacting with TBA, need not to provide the complete information on the extent of LPX in various biological systems. That was the reason why we decided to determine total TBARS in maternal plasma. This might help to estimate the total extent of LPX in maternal plasma, which was used, e.g., for study of LPX in this plasma in the process of labour (Yaacobi et al. 1999) .
The second aim of our study was to analyse the biochemical parameters in maternal pre-delivery and postdelivery plasma. It could provide information on the influence of process of labour on physiological functions and pathological changes of maternal tissues. Moreover, it could help to assess the association between levels of the biochemical parameters and LPX products levels and their production in maternal plasma during uncomplicated delivery.
Material and methods
Ten women delivering full-term newborns, involved in our study, had uncomplicated pregnancies and represented common town population living in Bratislava (Slovak Republic). All newborns showed no abnormalities during delivery and no defect of adaptation after their birth (measured by Apgar score). All women and their babies were patients of the Sub-department of Maternal-Foetal Medicine, Faculty of Medical Specialty Studies, Slovak Medical University in Bratislava. Maternal blood was collected into heparinised tubes in the first (pre-delivery blood) and third (post-delivery blood) stage of delivery by venous puncture from the antecubital vein.
LPX was investigated in vitro in maternal pre-delivery and post-delivery plasma in the 4 following experimental situations: (i) in non-incubated plasma without an added LPX activator (0-A), which represents the actual levels of LPX products; (ii) in non-incubated plasma with the added LPX activator (its concentration in incubation mixture was 125 µM L-ascorbic acid plus 5 µM FeSO4) (0+A), which can help to assess the intensity of LPX and presence of antioxidants; (iii) in incubated plasma (30 min, 37
• C) without the added LPX activator (30-A), which might provide information on development of LPX and formation of its products as well as on the presence of antioxidant and prooxidant factors; and (iv) in incubated plasma with the added LPX activator (30+A), which might provide information on the presence of suitable LPX substrates and on relation between prooxidant and antioxidant factors.
LPX products were determined as reactive substances by thiobarbituric acid adduction (TBARS) method described by Ohkawa et al. (1979) , with some modifications. 8.3 mM Tris-HCl buffer solution, pH 7.4, was added to all plasma samples. A half of the samples were incubated without or with the added LPX activator (its concentration in reactive mixture was 125 µM of L-ascorbic acid plus 5 µM of FeSO4) for 30 min at 37
• C. After addition of 2 % (v/v) H3PO4, and 0.6% (w/v) TBA, the samples were boiled for 45 min at 100
• C. The produced TBARS were extracted with n-butanol. After 10 min centrifugation at 3,000 r.p.m., absorbance of the upper n-butanol layer was measured spectrophotometrically at 532 nm. Even though, several LPX products reacting with TBA, except for MDA, precursor of MDA (1,1,3,3-tetraethoxypropane) was used for TBARS determination as a commonly used standard solution (Richard et al. 1992; Yagi 1993; Paşaoglu et al. 2004) . TBARS concentrations were calculated from the standard curve of MDA and expressed as nmol/mL of plasma.
Biochemical parameters: iron, total iron-binding capacity (TIBC), uric acid, total proteins, magnesium, calcium, inorganic phosphate, glucose, potassium, sodium, chlorides, and activities of enzymes: alanine aminotransferase (ALT), aspartate aminotransferase (AST), γ-glutamyltransferase (GMT), creatine kinase (CK), lactate dehydrogenase (LD), α-hydroxybutyrate dehydrogenase (HBD = isoenzyme LD1 and LD2), α-amylase (AMS), alkaline phosphatase (ALP), and acid phosphatase (ACP) were measured in maternal pre-delivery and post-delivery plasma by routine biochemical methods. The biochemical analyses were performed at the Clinic of Laboratory Medicine, Dérer Medical Faculty Hospital in Bratislava.
All the results are presented as means ± standard error of mean (SEM). Mann-Whitney U test was used for a pair-wise comparison. Spearman's rank correlation test (two-tailed analysis) was used for the correlation analysis. The level of statistical significance was set as p < 0.05 for all the tests. Table 1 summarizes the clinical characteristics of women and newborns included in this study. Gestational age and duration of labour were within physiological ranges. All newborns weights were appropriate to the gestational age of mothers and their Apgar score were within physiological ranges for the first and fifth minutes. TBARS values determined in the maternal predelivery and post-delivery plasma are shown in Figure  1 . Actual TBARS levels (0-A) were determined in nonincubated plasma without an added LPX activator. The actual TBARS values in post-delivery (2.71 ± 0.602 nmol/mL) plasma were not statistically different from those in pre-delivery plasma (3.45 ± 0.530 nmol/mL).
Results and discussion
The TBARS values in post-delivery plasma were similar to TBARS in maternal post-delivery plasma reported by Nakai et al. (2000) (2.31 nmol/mL) and Kobe et al. (2002) (2.4 nmol/mL). The values of actual TBARS in this study correspond to TBARS values (3.0 nmol/mL) measured in plasma of healthy women in the third trimester of pregnancy (Paşaoglu et al. 2004) as well as in the plasma of healthy non-pregnant women at an age of between 20 to 40 years (Yagi 1993) . Taking into account that all the monitored women and newborns showed no complications during delivery (Table 1), we consider our actual TBARS amounts as physiological values in maternal plasma at the end of the third trimester of pregnancy and immediately after delivery.
MDA, as the end product of LPX, forms MDA-TBA complex which was used for evaluation of LPX in maternal plasma in some clinical studies (Kharb et al. 1998; Rogers et al. 1999) . However, it is well known that there are also other LPX products reacting with TBA in blood plasma (Zima et al. 1995) . That was the reason why we decided to determine TBARS as indicator of the total extent of LPX in maternal plasma, similarly to other authors (Mutlu-Türkoglu et al. 1998; Yaacobi et al. 1999 ).
In some previous clinical studies, the increase of LPX intensity was observed in plasma of women with complications in the course of their pregnancies (Davidge et al. 1992; Kharb et al. 1998; Mutlu-Türkoglu et al. 1998 ). Other authors found that spontaneous delivery caused the increase of LPX products levels in plasma of newborns in comparison to those delivered by caesarean section (Rogers et al. 1998 ). According to some authors, TBARS could be used as a more sensitive indicator of foetal tissues injury caused by perinatal hypoxia than ABB parameters (Wang et al. 1996; Rogers et al. 1999) .
Regarding these facts, we wanted to find out whether changes in maternal tissues, caused by uncom- plicated delivery, could lead to changes in LPX intensity in maternal plasma. Although no differences were observed in actual TBARS values in pre-delivery versus post-delivery plasma (Fig. 1 ), in agreement with Nakai et al. (2000) , Kobe et al. (2002) and Orhan et al. (2003) , we evaluated the extent of LPX in maternal pre-delivery and post-delivery plasma not only by determination of actual TBARS but also by measurement of TBARS production in vitro in the both incubated plasma and plasma under the conditions of activated LPX.
A difference in TBARS levels found in the postdelivery plasma incubated without the added LPX activator (30-A) vs. the actual TBARS (0-A) was marginally significant (Fig. 1) . These findings suggest that changes in maternal tissues during uncomplicated delivery could activate LPX in maternal plasma. The similar activation of TBARS formation in vitro in umbilical cord plasma of newborns has been found in our previous study (Maceková et al. 2009 ). These results indicated the increase of the TBARS formation in mixed umbilical cord plasma of healthy full-term newborns in comparison with the actual TBARS levels (Maceková et al. 2009 ). According to these findings and the results obtained in this study, we assume that spontaneous uncomplicated delivery could cause the increase in the LPX products formation in umbilical cord plasma of newborns. This is consistent with the results of Yaacobi et al. (1999) , who found significantly higher TBARS in arterial umbilical cord plasma (originates in the foetus) than in maternal venous plasma in case of spontaneous deliveries, contrary to caesarean section deliveries.
Other findings of this study were that there are no changes in the TBARS formation in the incubated postdelivery plasma with the added LPX activator (30+A) in comparison with the non-incubated plasma with it a Data are presented as means ± SEM of 10 subjects. TIBC, total iron-binding capacity.
(0+A) or incubated plasma without it (30-A) (Fig. 1) . The probable explanation of the results could be that TBARS production in the post-delivery plasma might be limited by amounts of suitable substrates for LPX in this plasma. The biochemical parameters in maternal plasma reflect biochemical processes in organism of delivering women. All 20 analysed biochemical parameters in maternal pre-delivery and post-delivery plasma were within reference ranges for women (Avery et al. 1994) (Table 2) . No changes in these parameters were observed between the pre-delivery and the post-delivery plasma due to the process of labour. These results could suggest that there are no pathological changes in maternal tissues during uncomplicated delivery. Additionally, no correlations were found between these biochemical parameters and the TBARS in both plasma.
In conclusion, we did not observe differences in the actual TBARS levels as well as in the TBARS formation under each experimental condition between the post-delivery and pre-delivery maternal plasma. However, we found twice higher (marginally significant) TBARS formation in the incubated post-delivery plasma without the added LPX activator than the actual TBARS in this plasma, in contrast to the predelivery plasma. These results suggest that changes in maternal tissues in the process of labour might create suitable conditions for activation of LPX in maternal plasma.
